Ribon Therapeutics (Patented Solid Tumors Treatments) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Ribon Therapeutics (Patented Solid Tumors Treatments) General Information

Description

Patented drug for the treatment of cancer and solid tumors based in Japan. The drug suppresses tumor growth and enhances the immune reaction to tumor cells.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Japan
Primary Industry
Buildings and Property
Acquirer
ONO Pharmaceutical
Vertical(s)
Oncology
Corporate Office
  • Japan

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ribon Therapeutics (Patented Solid Tumors Treatments) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Ribon Therapeutics (Patented Solid Tumors Treatments)‘s full profile, request access.

Request a free trial

Ribon Therapeutics (Patented Solid Tumors Treatments) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Ribon Therapeutics (Patented Solid Tumors Treatments)‘s full profile, request access.

Request a free trial

Ribon Therapeutics (Patented Solid Tumors Treatments) FAQs

  • Where is Ribon Therapeutics (Patented Solid Tumors Treatments) headquartered?

    Ribon Therapeutics (Patented Solid Tumors Treatments) is headquartered in Japan.

  • What industry is Ribon Therapeutics (Patented Solid Tumors Treatments) in?

    Ribon Therapeutics (Patented Solid Tumors Treatments)’s primary industry is Buildings and Property.

  • Is Ribon Therapeutics (Patented Solid Tumors Treatments) a private or public company?

    Ribon Therapeutics (Patented Solid Tumors Treatments) is a Private company.

  • What is the current valuation of Ribon Therapeutics (Patented Solid Tumors Treatments)?

    The current valuation of Ribon Therapeutics (Patented Solid Tumors Treatments) is .

  • What is Ribon Therapeutics (Patented Solid Tumors Treatments)’s current revenue?

    The current revenue for Ribon Therapeutics (Patented Solid Tumors Treatments) is .

  • Who are Ribon Therapeutics (Patented Solid Tumors Treatments)’s investors?

    Ribon Therapeutics has invested in Ribon Therapeutics (Patented Solid Tumors Treatments).

  • When was Ribon Therapeutics (Patented Solid Tumors Treatments) acquired?

    Ribon Therapeutics (Patented Solid Tumors Treatments) was acquired on 02-Feb-2021.

  • Who acquired Ribon Therapeutics (Patented Solid Tumors Treatments)?

    Ribon Therapeutics (Patented Solid Tumors Treatments) was acquired by ONO Pharmaceutical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process